First Command Bank’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-100
Closed -$6K 377
2020
Q3
$6K Hold
100
﹤0.01% 283
2020
Q2
$8K Hold
100
﹤0.01% 267
2020
Q1
$7K Hold
100
﹤0.01% 281
2019
Q4
$6K Sell
100
-7
-7% -$456 ﹤0.01% 332
2019
Q3
$7K Hold
107
﹤0.01% 331
2019
Q2
$7K Sell
107
-75
-41% -$4.93K ﹤0.01% 347
2019
Q1
$12K Hold
182
0.01% 320
2018
Q4
$11K Buy
182
+75
+70% +$5.24K 0.01% 330
2018
Q3
$8K Hold
107
﹤0.01% 338
2018
Q2
$8K Buy
+107
New +$7.56K ﹤0.01% 356
2017
Q3
Sell
-147
Closed -$10K 416
2017
Q2
$10K Hold
147
0.01% 346
2017
Q1
$10K Sell
147
-240
-62% -$16.9K 0.01% 329
2016
Q4
$28K Buy
+387
New +$28.8K 0.02% 246

Other funds holding GILD

First Command Bank's GILD Position: Q4 2020 in Review

First Command Bank sold out of Gilead Sciences (GILD) in Q4 2020, closing a stake of 100 shares — an estimated $6K sold.

First Command Bank first reported a position in GILD in Q4 2016 and held it in 13 quarters. The position peaked at $28K in Q4 2016. 1,563 funds tracked by Wall St. Rank hold GILD as of Q4 2020.

  • First Command Bank reported no remaining Gilead Sciences position as of Q4 2020 after selling out during the quarter.
  • First Command Bank sold 100 Gilead Sciences shares in Q4 2020, an estimated $6K.
  • First Command Bank first reported a position in Gilead Sciences in Q4 2016 and held it in 13 quarters.
  • First Command Bank's Gilead Sciences position peaked at $28K in Q4 2016.
  • 1,563 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2020.

Based on First Command Bank's 13F filing for Q4 2020, filed 19 Jan 2021.